Literature DB >> 2376592

Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily.

T K Sampath1, J E Coughlin, R M Whetstone, D Banach, C Corbett, R J Ridge, E Ozkaynak, H Oppermann, D C Rueger.   

Abstract

A bone-inductive protein has been purified from bovine bone and designated as osteogenic protein (OP). The purified OP induces new bone at less than 5 ng with half-maximal bone differentiation activity at about 20 ng/25 mg of matrix implant in a subcutaneous bone induction assay. The purified osteogenic protein is composed of disulfide-linked dimers that migrate on sodium dodecyl sulfate gels as a diffuse band with an apparent molecular weight of 30,000. Upon reduction, the dimers yield two subunits that migrate with molecular weights of 18,000 and 16,000. Both subunits are glycosylated. After chemical or enzymatic deglycosylation, the dimers migrate as a diffuse 27-kDa band that upon reduction yields two polypeptides that migrate at 16 kDa and 14 kDa, respectively. The carbohydrate moiety does not appear to be essential for biological activity since the deglycosylated proteins are capable of inducing bone formation in vivo. Amino acid sequences of peptides generated by proteolytic digestion show that the subunits are distinct but related members of the transforming growth factor-beta super-family. The 18-kDa subunit is the protein product of the bovine equivalent of the human OP-1 gene and the 16-kDa subunit is the protein product of the bovine equivalent of the human BMP-2A gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2376592

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone.

Authors:  A J Celeste; J A Iannazzi; R C Taylor; R M Hewick; V Rosen; E A Wang; J M Wozney
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure.

Authors:  S J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  Bone morphogenic proteins: applications in spinal surgery.

Authors:  Gerard K Jeong; Harvinder S Sandhu; James Farmer
Journal:  HSS J       Date:  2005-09

Review 4.  [Osteoinduction and -reparation].

Authors:  N R Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  1997-02

5.  Use of OP-1 (rhBMP-7) in posterolateral lumbar arthrodesis.

Authors:  Jetan H Badhiwala; Michael G Fehlings
Journal:  J Spine Surg       Date:  2016-12

Review 6.  BMP signaling in vascular development and disease.

Authors:  Jonathan W Lowery; Mark P de Caestecker
Journal:  Cytokine Growth Factor Rev       Date:  2010-07-31       Impact factor: 7.638

Review 7.  Bone Morphogenetic Proteins.

Authors:  Takenobu Katagiri; Tetsuro Watabe
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

Review 8.  Deglycosylation of glycoproteins with trifluoromethanesulphonic acid: elucidation of molecular structure and function.

Authors:  Albert S B Edge
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

9.  Drosophila transforming growth factor beta superfamily proteins induce endochondral bone formation in mammals.

Authors:  T K Sampath; K E Rashka; J S Doctor; R F Tucker; F M Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

10.  Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis.

Authors:  Shawn C Little; Mary C Mullins
Journal:  Nat Cell Biol       Date:  2009-04-19       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.